天美传媒

Andrew J. Gerber, MD, PhD, is medical director and CEO of the Austen Riggs Center and an associate clinical professor in the Division of Child and Adolescent Psychiatry at Columbia University Medical Center. He is an associate clinical professor at the Child Study Center, Yale University. He is an adjunct associate professor of Psychological & Brain Sciences in the College of Natural Sciences at University of Massachusetts Amherst. He is the former co-director of the Sackler Parent-Infant Program at Columbia University, former director of the MRI Research Program at the New York State Psychiatric Institute, and former director of research at the Columbia University Center for Psychoanalytic Training and Research. While in New York, he also had a private psychoanalytic practice.

Dr. Gerber completed a PhD in psychology at the Anna Freud Centre and University College London where he studied with Peter Fonagy and Joseph Sandler, investigating the process and outcome of psychoanalysis and psychoanalytic psychotherapy in young adults. He completed his medical and psychiatric training at Harvard Medical School, Cambridge Hospital, and Weill Cornell and Columbia medical schools and his psychoanalytic training at Columbia. He trained as a research fellow with Bradley Peterson at the New York State Psychiatric Institute in brain imaging and child psychiatry. He has published and received grants in the areas of developmental psychopathology, attachment, and functional neuroimaging of dynamic processes, including social cognition and transference. He has also been involved in planning and teaching psychoanalytic research as head of the Science Department at the American Psychoanalytic Association and chair of the Committee on Scientific Activities, secretary of the Psychoanalytic Psychodynamic Research Society, and a member of the psychotherapy research committees of the American Academy of Child and Adolescent Psychiatry.

Dr. Gerber is married to Andrea Gerber, PhD, who is a clinical psychologist. They have two young daughters, Samantha and Lila.

Dr. Gerber鈥檚 published scholarship shows his deep passion for research. For a list (and downloadable copies) of Dr. Gerber's publications, see: http://www.researchgate.net/profile/Andrew_Gerber

Dr. Maidenberg has been teaching and supervising clinicians and psychiatry residents for over 25 years. He provides cognitive behavioral therapy for a variety of anxiety disorders and depression.

Dr. Amit Shahane, PhD, is a clinical psychologist who serves as the director of the Behavioral Medicine Center at the University of Virginia Health System. Dr. Shahane specializes in treating psychological disorders, including PTSD, that impact medical illness. His research interests include examining the effectiveness of cognitive and behavioral treatments for insomnia, as well as healthcare utilization research, such as the effect of HIV stigma.

UVA's Behavioral Medicine Center diagnoses, treats and prevents medical problems either caused or aggravated by lifestyle or stress, including:
鈥�	Depression and anxiety
鈥�	Migraine and tension headaches
鈥�	Nervous stomach and irritable bowel syndrome
鈥�	Sleep problems
鈥�	Eating disorders


Listen to Shahane discuss sleep problems:
http://wina.com/morning-news/dr-amit-shahane-live-well/

Shahane discusses PTSD:
http://www.newsplex.com/content/news/Fourth-of-July-fireworks-potential-PTSD-trigger-for-area-veterans-385267411.html

In 2008, Heidi Zinzow joined Clemson鈥檚 College of Behavioral, Social and Health Sciences as an assistant professor in the Department of Psychology, bringing her knowledge as a licensed clinical psychologist into the classroom. Her work addresses factors that put individuals at risk of developing psychological symptoms due to trauma exposure, how to ameliorate related mental health symptoms and what the protective factors are. Applying science to practice and vice versa, she focuses on the development of intervention and prevention programs to improve a victim鈥檚 well-being, quality of life, and occupational and social functioning.

Zinzow鈥檚 in-depth understanding of different types of trauma spans sexual assault, interpersonal violence and mass violence. She examines trauma-related mental health outcomes including post-traumatic stress disorder and depression. Additionally, she has moved into substance use disorders 鈥揳nd risky substance use 鈥揳s a mechanism for violence perpetration and exposure. Another stream of her research is suicide prevention: how to develop efficacious programs that improve community members鈥� abilities to identify those at risk, ask difficult questions and provide support. 

With intervention and prevention program development, she examines technology-based tools such as virtual reality, online methodologies and digital apps to deliver programming. Along with other novel applications of technology to help advance the field, Zinzow looks at the role of social media and the propagation of harmful behavior. 

In clinical practice, she has analyzed intergenerational transmission of trauma, substance use and mental illness and how these variables affect each other. Working with the military, she has explored mental health and exposure to stress, combat and trauma, including military sexual assault. An as an expert consultant, she has investigated ways to work with communities to better address mass violence exposure. 

In collaboration, Zinzow has authored over 50 publications in scientific,peer-reviewed journals, which include 鈥淛ournal of Traumatic Stress,鈥� 鈥淛ournal of Interpersonal Violence,鈥� 鈥淐linical Psychology Review鈥� and 鈥淛ournal of Clinical and Consulting Psychology.鈥�

She co-founded Tigers Together to Stop Suicide, currently serves as an expert consultant for the National Mass Violence and Victimization Resource Center, and helps lead Clemson's NSF Tigers ADVANCE  initiative to improve campus gender equity.  She has received an  Emerging  Scholar Research  Excellence  Award and  Excellence in  Service and  Outreach  Award,  as well as an Outstanding Woman Faculty Member Award from the President's Commission on Women. 

Before joining Clemson, Zinzow completed a postdoctoral fellowship in traumatic stress with the National Crime Victims Research & Treatment Center at the Medical University of South Carolina (MUSC). In addition to her practice as a licensed clinical psychologist, she has served at many domestic violence and sexual assault centers. In her early career, she worked as a research assistant for Caliber Associates in Northern Virginia, outside of Washington, D.C., evaluating social programs that addressed domestic violence, child maltreatment and juvenile delinquency.

Dr. Rita Cowell is Fellow and Chair of the Neuroscience Department within the Drug Discovery Division. In this role, she maintains an independently-funded research program, while overseeing the Neuroscience Department with the mission of discovering novel, mechanism-based approaches to treat individuals with neurodegenerative disorders. The research in the Cowell Lab aims to determine how intrinsic transcriptional programs underlying neuronal heterogeneity give rise to selective vulnerability in neurodegenerative disorders such as Parkinson鈥檚 Disease, Huntington Disease, Amyotrophic Lateral Sclerosis, and Alzheimer鈥檚 Disease. Her research group is comprised of postdoctoral, graduate, and undergraduate trainees who are affiliated with Southern Research鈥檚 partner institution, the University of Alabama at Birmingham (UAB). The lab is currently supported by grants from the National Institutes of Health and the Michael J. Fox Foundation for Parkinson鈥檚 Research.

Cowell received her undergraduate degree in biology in 1997 from the University of Illinois at Urbana-Champaign and her Ph.D. in neuroscience in 2002 from the University of Michigan, where she also completed her postdoctoral work. She began her independent research laboratory as an assistant professor at UAB in 2006, rising through the ranks to associate professor. She also served as co-director of the Neuroscience Graduate Theme for the Program in Biomedical Sciences at UAB and associate director for Communications and Outreach for the Civitan International Research Center before joining Southern Research in 2017.  

Using a think tank-like model, she now directs the Neuroscience Department, utilizing its collective expertise in mechanisms of cell death/dysfunction and animal models of disease to identify and prioritize novel targets for small molecule identification using the unique high throughput capabilities of the Drug Discovery Division. Beyond these efforts to the institution, she actively facilitates interactions with local, national, and international groups interested in drug discovery and development in the neurosciences by serving as a liaison and consultant for extramural collaborations. Ongoing collaborations exist with scientists from UAB, HudsonAlpha in Huntsville, Alabama, and numerous other institutions, universities, and companies across the world. Cumulatively, her goal is to lead transformation of drug discovery in the field of neurodegeneration and to improve the lives of those suffering from these diseases.

Dr. Fredric Rabinowitz is a professor of psychology and associate dean at the University of Redlands and psychotherapist who specializes in working with men. He is a nationally recognized expert on the study of men and masculinity, and depression in men. Dr. Rabinowitz is one of the key architects and authors of the American Psychological Association's recently released, first-ever "2018 Guidelines for Psychological Practice with Boys and Men," a project of which he has been the steward since 2005. He is currently working on a book and has authored many articles and book chapters.

Ricardo F. Mu帽oz, Ph.D. is a depression prevention and treatment researcher and Distinguished Professor of Clinical Psychology at Palo Alto University. From 1977 to 2012, he was professor of psychology at the School of Medicine of the University of California, San Francisco (UCSF), based at San Francisco General Hospital (SFGH), where he served as Chief Psychologist for 26 years. Dr. Mu帽oz has been the recipient of many awards, including the Martin Luther King, Jr. Award from UCSF and the George Sarlo Award for Excellence in Teaching from the UCSF Department of Psychiatry. He is now Professor Emeritus at UCSF. He has been a pioneer in the development of Internet interventions for health since the 1990鈥檚 and was a founding member of the board of directors for the International Society for Research on Internet Interventions from 2010 to 2013. He has most recently founded i4Health, an institute dedicated to developing, evaluating, and disseminating evidence-based psychological interventions in multiple languages for people worldwide using Internet sites and mobile applications.

Mu帽oz immigrated from Per煤 to the Mission District in San Francisco in 1961, at age 10. He did his undergraduate work at Stanford and his doctorate at the University of Oregon in Eugene. He was the first psychologist to join the faculty of the UCSF Department of Psychiatry at San Francisco General Hospital in 1977. In 1985, he founded the SFGH Depression Clinic, the first cognitive-behavioral service at UCSF. He became Chief Psychologist at SFGH in 1986, and Director of the Clinical Psychology Training Program from 1992 to 2012. His research focuses on the development of prevention and treatment interventions for depression and applications of these methods to help people stop smoking. He founded the UCSF/SFGH Latino Mental Health Research Program in 1992. He began work on international randomized trials via the Internet in 1998, and founded the UCSF/SFGH Internet World Health Research Center in 2004. He was the PI on the first randomized controlled trial to prevent major depression. He has served on both Institute of Medicine committees which produced major reports on prevention of mental disorders in 1994 and 2009. His latest contributions to the area of prevention of depression include articles in the Annual Review of Clinical Psychology (2010), the American Psychologist (2012), and a chapter in the Handbook of Depression (2014).

Donna Sheperis, PhD. joined PAU in 2016 and currently serves as an Associate Professor, Associate Chair for Clinical Training, Chair of the PAU Faculty Senate, and Co-Chair of the PAU Institutional Review Board. Dr. Sheperis is a board certified tele-mental health therapist. She earned her Ph.D. in Counselor Education from the University of Mississippi and her masters in Counseling from Delta State University. Donna has taught for land based and online programs since 2000. She is a Licensed Professional Counselor in Mississippi and Texas; a Board Certified Counselor; a Board Certified Clinical Mental Health Counselor; and an Approved Clinical Supervisor with 30 years of experience in clinical mental health counseling settings. 

Dr. Donna Sheperis is active in the counseling profession. She is past-president of the Association for Assessment and Research in Counseling and on the Ethics Appeals Committee for the American Counseling Association. Previously, Donna served as chair of the ACA Ethics Committee. She also serves on the Ethics and Bylaws committees for the Association for Humanistic Counseling and the Western Association for Counselor Education and Supervision. She is active in scholarship and research as well with multiple articles in peer reviewed journals. In addition, she has authored multiple book chapters and textbooks including Clinical Mental Health Counseling: Fundamentals of Applied Practice for Pearson Publishing; Ethical Decision Making for the 21st Century Counselor for SAGE Publishing; and Foundations of Substance Use and Addiction Counseling: Principles and Applied Practice for Cognella Publishing (in press).

 

Tracy R. G. Gladstone, Ph.D., is an associate director and senior research scientist at the Wellesley Centers for Women as well as the inaugural director of the Robert S. and Grace W. Stone Primary Prevention Initiatives, which aims to research, develop, and evaluate programs to prevent the onset of depression and other mental health concerns in children and adolescents. She is also an assistant in psychology at Boston Children鈥檚 Hospital, an instructor at Harvard Medical School, and a research scientist at Judge Baker Children鈥檚 Center.

At the Wellesley Centers for Women, Gladstone is evaluating an internet-based depression prevention intervention for at-risk adolescents in a multi-site, federally funded trial. As a senior member of the Baer Prevention Initiatives Dissemination Program at Boston Children鈥檚 Hospital, she is working on developing and disseminating web-based educational resources for clinicians and for parents who are concerned about depression. She has served as a senior member of the Preventive Intervention Project research team at Judge Baker Children鈥檚 Center, which compares two family-based prevention programs for early adolescents at risk for depression because they have a parent with a depressive disorder. She also has developed and piloted a cognitive-behavioral group intervention for women who are recovering from fistula repair surgery in Ethiopia.

Gladstone holds a health service provider psychologist license in Massachusetts and has been trained in evidence-based clinical prevention and intervention protocols. She has conducted prevention-oriented work with children and families, and she has served as a clinical supervisor for researchers working with depressed families, as well as for clinical trainees. She has co-authored a number of peer-reviewed manuscripts reporting the results of her research endeavors and has taken an active role in teaching about depression, prevention, and intervention in local, national, and international settings.

Christopher M. Palmer, MD, received his medical degree from Washington University School of Medicine and completed his internship and psychiatry residency at McLean Hospital, Massachusetts General Hospital, and Harvard Medical School. He is currently the director of the Department of Postgraduate and Continuing Education at McLean Hospital and an assistant professor of psychiatry at Harvard Medical School.

For over 20 years, Dr. Palmer鈥檚 clinical work has focused on treatment resistant cases, and recently he has been pioneering the use of the ketogenic diet in psychiatry, especially treatment resistant cases of mood and psychotic disorders.

Brett Wingeier, Ph.D., is co-founder and chief executive officer of Magnus Medical and a member of its Board of Directors. He brings over 20 years of experience in the development and commercialization of advanced neurotechnology. Most recently, he was a co-founder of Halo Neuroscience, where he was chief technology officer and later assumed the additional role of CEO. During his tenure at Halo, he raised $26 million over seven years to commercialize non-invasive electrical brain stimulation across consumer and medical applications. He was also the architect of Halo Sport, the world鈥檚 first consumer neurostimulation headset for movement training, as well as the company鈥檚 next-generation products, which remain under development for cognitive and psychiatric health. As CTO, he built and supervised hardware and software development teams, led Halo鈥檚 applied neuroscience research program, led manufacturing operations in the U.S. and Asia, and managed IP and regulatory affairs. As CEO, he additionally supervised clinical affairs, distribution, e-commerce, direct-to-consumer sales, partnerships, marketing, and customer support for Halo鈥檚 portfolio of products. 

Before co-founding Halo, Dr. Wingeier was one of the first employees at NeuroPace, where he co-developed the world鈥檚 first responsive neurostimulator for epilepsy鈥攃alled the RNS System鈥攚hich received PMA approval from the U.S. Food & Drug Administration (FDA) in 2013. At NeuroPace, he was the principal biomedical engineer responsible for firmware engineering, clinical science, biostatistics, and product management. Today, the RNS System is an accepted treatment for intractable epilepsy, with over 2,000 implants and 82% seizure frequency reduction. In parallel, he was instrumental in the development and clinical trial of Autonomic Technologies鈥� Pulsante implant, which attained CE Mark certification to treat cluster headaches in 2012, and migraine headaches in 2017. 

Dr. Wingeier received a Bachelor of Science in Biomedical Engineering and his Ph.D. in Biomedical Engineering, both from Tulane University. He has completed additional studies at Swinburne University鈥檚 Brain Science Institute and at Stanford Biodesign. Dr. Wingeier is a registered patent agent, a prolific inventor with over 60 issued U.S. patents, and a member of the IEEE Working Group on Neuroethics.

Alinne Barrera, PhD is a California licensed clinical psychologist with a specialty in working with Spanish-speaking and Latinx communities. Her scholarly work is focused on depression prevention, intervention adaptations, and the use of technology to deliver maternal mental health resources. As a trainee, she built a strong foundation in the detection and treatment of major depression using standardized measures and evidence-based interventions. During the past 15 years Dr. Barrera has dedicated her research program to adapting and empirically testing internet and SMS versions of the Mothers and Babies Course/Curso Mam谩s y Beb茅s, a prevention of postpartum depression intervention recently recognized by the US Prevention Services Task Force. She is committed to working with clinicians and trainees who aim to reduce mental health disparities, especially among new mothers. Dr. Barrera is an Associate Professor in the Clinical Psychology PhD Program at Palo Alto University and serves as Associate Director at the Institute for International Internet Interventions for Health (i4Health). She is a 2020 Mom Board Member and serves on the Editorial Board of the Journal of Latinx Psychology. She completed her undergraduate degree at the University of California, Berkeley, her doctoral degree at the University of Colorado, Boulder, and her predoctoral internship and postdoctoral fellowship at the University of California, San Francisco.

Nicholas Mazza, PhD, is Professor and Dean Emeritus at the Florida State University, College of Social Work, Tallahassee, FL. Dr. Mazza holds Florida licenses in psychology, clinical social work, and marriage and family therapy. He's been involved in the practice, research, and teaching of poetry therapy for over 40 years. He says that poetry鈥檚 unique use of language, symbol, story and rhythm has been effective in therapeutic settings. And while typically a solitary act, sharing poetry can provide additional healing and support.

Dr. Mazza is the author of Poetry Therapy: Theory and Practice, 3rd Edition (2022); and Editor of a 4-volume series, Expressive Therapies (published by Routledge). He is also the founding (1987) and continuing editor of the Journal of Poetry Therapy: The Interdisciplinary Journal of Practice, Theory, Research, and Education. He is president and continuing board member of the National Association for Poetry Therapy (NAPT). In 1997, Dr. Mazza received the Pioneer Award; and in 2017, the "Lifetime Achievement Award" from NAPT.

He can:
-Discuss why poetry is in a 鈥渇ull on鈥� renaissance
-Discuss why poetry is such a simple yet powerful therapeutic practice
-How writing poetry impacts positive mental and emotional health
-Poetry鈥檚 unique ability to express emotions and provide release
-How poetry can assist in coping with loss, recovery, trauma, violence and more
-Yet, it can also connect people and build community and support
-Offer tips and advice on getting started with poetry for therapy

Dr. Mazza is a widely published scholar and poet. He can offer tips and advice for getting started with poetry, discuss why it is such a therapeutic practice, why it is seeing a renaissance. In addition to poetry therapy, Dr. Mazza has practiced, taught, and published in the areas of crisis intervention, death and trauma, family therapy, group work, clinical theories and models, and the arts in community practice. Dr. Mazza, a marathon runner, is the founder of the College of Social Work Arts and Athletics Community Outreach Program for At-Risk Youth established at Florida State University (FSU) in 2011.

Katharine Sperandio, PhD, joined the Clinical Mental Health Counseling (CMHC) faculty as an Assistant Professor at Saint Joseph鈥檚 University in 2022. She is currently the CACREP-accreditation coordinator for the CMHC program. She completed her PhD in Counselor Education and Supervision at CACREP-accredited William & Mary in 2019. Her research is inspired by her work as a Licensed Professional Counselor (LPC), which has granted her the opportunity to work with a variety of populations, including those living with addictions. She actively serves clients in the Philadelphia community so that she can continue to use her clinical experiences to inform her teaching and scholarship. The mission of her research agenda is to increase understanding on how to help those living with addiction promote and sustain their recovery and how to optimally support families who are impacted by addiction. She has also explored topic areas that pertain to supporting mental health and addictions counselors who are undergoing chronic stress. In addition to this work, she co-constructed the Multidimensional Cultural Humility Scale (MCHS) with her colleagues to assess levels of cultural humility among mental health and school counselors. She has worked with colleagues on multiple research projects to investigate how to support students in learning how to be more culturally responsive and trauma-informed in their clinical practice. As of 2022, she was invited to serve as an Associate Editor for The Professional Counselor, which she accepted with great elation.

, is a psychiatrist and internationally recognized expert in treating severe psychiatric disorders with magnetic brain stimulation, also known as transcranial magnetic stimulation (TMS).
He uses TMS to help patients with treatment-resistant depression and is the director of UC San Diego Health's Interventional Psychiatry Clinic, the region's largest clinic dedicated to treating severe depression with brain stimulation approaches.
As chair of the Department of Psychiatry at UC San Diego School of Medicine, Daskalakis is leading research on the use of TMS in people with treatment-resistant schizophrenia, suicidal thoughts and obsessive compulsive disorders. Treatment-resistant diseases are those that may not be resolved adequately through traditional medications and talk therapy alone.
Daskalakis says the most rewarding aspect of his clinical practice is being able to help people who have not found relief through conventional approaches. This is why his research focuses on novel approaches such as brain stimulation for treating mental health conditions.

Florin Dolcos is a professor of psychology at the University of Illinois Urbana-Champaign and a full-time faculty member at the Beckman Institute for Advanced Science and Technology.
He performed his Ph.D. research in cognitive and affective neurosciences at the University of Alberta’s Centre for Neuroscience and Duke University’s Centre for Cognitive Neuroscience, and his postdoctoral training in cognitive, affective, and clinical neurosciences at Duke University’s Brain Imaging and Analysis Center. Dolcos joined the University of Illinois following an assistant professor appointment in the University of Alberta’s Department of Psychiatry.
Research 
Dolcos researches the neural correlates of affective-cognitive interactions in healthy and clinical populations, as studied with brain imaging techniques such as functional MRI and ERP. His program can be divided into the following main directions:

Neural Mechanisms Underlying the Impact of Emotion on Cognition. 
This direction investigates the mechanisms underlying the enhancing and impairing effects of emotion on various cognitive/executive processes (perception, attention, working memory, episodic memory, decision making). A novel direction emerging from this research investigates the neural mechanisms linking and dissociating the opposing effects of emotion. This is important because they tend to co-occur in both healthy functioning and clinical conditions. For instance, enhanced distraction produced by task-irrelevant emotional information can also lead to better memory for the distracters themselves. Also, enhanced memory for traumatic events in PTSD can also lead to impaired cognition due to increased emotional distractibility.

2. Neural Mechanisms Underlying the Impact of Cognition on Emotion. 
The impact of cognition on emotion is typically exerted as cognitive control of emotion, or emotion regulation. This direction is corollary to my first direction, and is important to pursue, because optimal cognitive control of emotional responses is a key component of healthy emotional behavior, whereas maladaptive regulation strategies constitute a core feature of affective disorders. Thus, in our studies we also manipulate emotion regulation strategies (e.g., suppression, reappraisal, attentional deployment), to investigate the regulatory mechanisms mediating the beneficial or detrimental impact of emotion on cognition.

3. Neural Mechanisms of Emotion-Cognition Interactions in Social Contexts. 
My research also targets mechanisms of emotion-cognition interactions in social contexts. This newly emerging direction in my research program is also important, because proper processing and interpretation of emotional social cues are key components of successful social behavior. Therefore, we are also investigating the neural mechanisms of processing emotional information as social cues, and of their impact on behavior.

4. The Role of Individual Differences in Emotion-Cognition Interactions. 
Although the first three lines of research have clear clinical relevance, it is important to also directly investigate the very same issues in clinical cohorts. Therefore, my research program also includes collaborations with clinical researchers that investigate neural mechanisms of emotion-cognition interactions in patients with mood and anxiety disorders (depression, PTSD), as well as investigation of changes associated with therapeutic interventions. Investigation of individual differences, however, is important not only for understanding clinical conditions, but also for integrative understanding of the factors that influence individual variation in the vulnerability to, or resilience against, emotional and cognitive challenges leading to disturbances. Thus, in my research, I have also investigated the role of gender, age, personality, and genetic differences in emotion-cognition interactions. Especially relevant are emerging large-scale studies using comprehensive behavior-personality-brain approaches emphasizing integrative understanding that is critical for the development of training and preventive programs aimed to increase resilience and reduce vulnerability to emotional disturbances.

 is a professor in the Department of Psychology at the University of Illinois Urbana-Champaign, a researcher at the Beckman Institute for Advanced Science and Technology and an affiliate at the Center for Social & Behavioral Science at Illinois.
The goal of Rudolph’s research is to identify risk and protective processes that amplify or attenuate vulnerability to psychopathology across development, with a focus on adolescence as a stage of particular sensitivity.
Her research uses an interdisciplinary, multi-level, multi-method approach that bridges across developmental and clinical psychology and social affective neuroscience. In particular, her research considers how personal attributes of youth (e.g., gender, temperament, emotion regulation, social motivation, coping, neuroendocrine profiles, neural processing), development (e.g., puberty, social transitions), and contexts (e.g., early adversity, stressors, family and peer relationships) intersect to contribute to the development of psychopathology, particularly depression and suicide. This research aims to understand both the origins and consequences of individual differences in risk.
Her lab uses a variety of methodological approaches, including longitudinal survey-based research, interviews, behavior observations, experimental tasks, hormone assessments and fMRI. Recent work also involves the development of a prevention program for adolescent depression.
Rudolph received her doctorate in clinical psychology at the University of California, Los Angeles, and completed a clinical internship at the Neuropsychiatric Institute and Hospital (now the Semel Institute for Neuroscience and Human Behavior) at UCLA before joining the faculty at Illinois. She served as co-editor of the "Handbook of Developmental Psychopathology" and an associate editor for the Journal of Clinical Child and Adolescent Psychology. She has served as a PI and co-PI on several large-scale longitudinal studies funded by the National Institutes of Health.